Jan Skvarka - 30 Mar 2023 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
Director
Signature
/s/ Ajim Tamboli, Attorney-in-Fact
Issuer symbol
GLUE
Transactions as of
30 Mar 2023
Net transactions value
$0
Form type
4
Filing time
31 Mar 2023, 16:15:14 UTC
Previous filing
24 Mar 2023
Next filing
15 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLUE Stock Option (Right to Buy) Award $0 +41,000 $0.000000 41,000 30 Mar 2023 Common Stock 41,000 $7.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in 36 substantially equal monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.